Rhumbline Advisers Celularity Inc Transaction History

Rhumbline Advisers

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.22 - $0.56 $1,479 - $3,766	-6,725 Reduced 78.04%	1,892 $0
Q2 2023 Aug 08, 2023	SELL	$0.42 - $0.81 $19,095 - $36,826	-45,465 Reduced 84.07%	8,617 $4,000
Q1 2023 May 11, 2023	BUY	$0.56 - $1.15 $1,248 - $2,563	2,229 Added 4.3%	54,082 $34,000
Q4 2022 Feb 14, 2023	BUY	$1.08 - $2.35 $10,686 - $23,253	9,895 Added 23.58%	51,853 $67,000
Q3 2022 Nov 10, 2022	BUY	$0.43 - $4.31 $9,985 - $100,086	23,222 Added 123.94%	41,958 $97,000
Q2 2022 Aug 11, 2022	BUY	$2.81 - $12.91 $52,648 - $241,881	18,736 New	18,736 $64,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $296M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.